Fortis Hospital, Mulund, Mumbai – India
About Dr. Amol Balvant Akhade
Dr. Amol Balvant Akhade is a highly distinguished Consultant in Medical Oncology and Haemato-Oncology, recognised as a leading oncologist in India. With over 18 years of experience, he has dedicated his career to treating complex cancer cases with a focus on personalised approaches and innovative therapies. Trained at the prestigious Tata Memorial Hospital in Mumbai, Dr. Akhade possesses profound expertise in managing solid tumours and haematologic malignancies. He is particularly renowned for his skills in performing both autologous and allogeneic bone marrow transplants and implementing cutting-edge immunotherapy protocols. Beyond clinical practice, he is an active researcher and DNB faculty member, contributing significantly to medical literature in reputed journals like The Lancet Oncology. His commitment to evidence-based medicine and compassionate care makes him a top cancer doctor in India for patients seeking advanced treatment outcomes.
Qualifications & Credentials
Medical Degrees:
- DM (Medical Oncology): Tata Memorial Hospital, Mumbai (2010)
- MD (Medicine): GS Medical College & KEM Hospital, Mumbai (2007)
- MBBS: GS Medical College & KEM Hospital, Mumbai (2003)
- Specialised training in Medical Oncology and Haemato-Oncology at Tata Memorial Hospital, a premier cancer institute in India.
- Advanced training in Autologous and Allogeneic Bone Marrow Transplantation.
- DNB Faculty for Medical Oncology.
- Recognised speaker at national and international oncology forums.
- Member of multidisciplinary tumour boards involving complex cancer management.
Areas of Expertise
Major Cancer Types Treated:
- Breast Cancer (HR+/HER2-, Triple Negative)
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Lung Cancer (NSCLC)
- Gastrointestinal Cancers
- Gynaecological Cancers
- Haemato-Oncology (Lymphoma, Leukaemia, Myeloma)
- Geriatric Oncology
- Precision Oncology
- Bone Marrow Transplantation: Expert in performing both Autologous and Allogeneic transplants.
- Immunotherapy: Administration of checkpoint inhibitors (PD-1/PD-L1) for various malignancies.
- Targeted Therapy: Utilising CDK4/6 inhibitors and other molecularly targeted agents.
- Chemotherapy Management: Handling complex regimens and managing chemotherapy-induced toxicities.
Professional Experience
Current & Past Hospital Affiliations:
- Current Affiliation: Consultant Medical Oncology, Fortis Hospital, Mulund.
- Past Affiliations: Consultant, Dr. L H Hiranandani Hospital, Mumbai.
Academic & Research Roles:
- DNB Faculty: actively involved in teaching and mentoring postgraduate medical students.
- Researcher: Deep interest in real-world data in oncology and clinical trials.
- Reviewer & Author: Contributor to high-impact journals such as the Indian Journal of Medical and Paediatric Oncology and The Lancet Oncology.
Key Achievements & Contributions:
- Played a pivotal role in advancing the understanding of immunotherapy in Head and Neck Cancer treatment.
- Conducted significant research on "Low-dose Anti-PD-(L)1 agents," addressing cost-effective strategies for cancer care in low-and-middle-income countries (LMICs).
- Published extensive reviews on optimizing strategies for Advanced Breast Cancer.
Awards & Recognitions
National & International Awards:
- Recognised for extensive research contributions in the field of cost-effective immunotherapy strategies.
Recognitions & Honours:
- Invited Speaker at various national oncology conferences.
- Authored multiple practice-changing articles and systematic reviews in global oncology journals.
Research & Publications
Dr. Amol Akhade is a prolific researcher with numerous publications in high-indexed journals. Below is a selection of his work:
Published Papers in Medical Journals:
- Immunotherapy Makes Inroads in Head and Neck Cancer Treatment, Indian Journal of Medical and Paediatric Oncology, (2025)
- Subcutaneous immunotherapy-a wolf in sheep's clothing?, The Lancet Oncology, (2025)
- Optimizing Post-CDK4/6i Strategies In HR +/HER2− Advanced Breast Cancer: A Contemporary Evidence-Based Framework, Indian Journal of Medical and Paediatric Oncology, (2025)
- Low-dose anti-PD-(L)1 inhibitor strategies: A systematic review, Journal of Clinical Oncology, (2025)
- Expanding Access to Cancer Immunotherapy: A Systematic Review of Low-Dose PD-(L)1 Inhibitor Strategies, European Journal of Cancer, (2025)
- Burnout among Oncologists in India: Challenges in Outpatient Department Practice and the Way Forward, Indian Journal of Medical and Paediatric Oncology, (2025)
- Geriatric oncology in LMICs: it is time to mature, BMJ Oncology, (2024)
- Consensus Guidelines for the Use of Cyclin-Dependent Kinase (CDK) 4/6 Inhibitors in the Management of Hormone Receptor Positive (HR+ve), Her2−ve Early Breast Cancer (EBC), South Asian Journal of Cancer, (2024)
- 2306P Low-dose Anti-PD-(L)1s agents in immune-oncology: Are we prepared?, Annals of Oncology, (2025)
Books & Chapters Authored:
- Book Review: Tata Memorial Centre Textbook of Oncology, Indian Journal of Medical and Paediatric Oncology, (2025)
Patient Success Stories & Testimonials
Notable Cases Handled:
- Successfully managed a complex case of metastatic Head and Neck cancer using a personalised immunotherapy protocol, resulting in significant disease regression.
- Performed life-saving Allogeneic Bone Marrow Transplants for patients with high-risk leukaemia.
- Guided numerous elderly patients through "Geriatric Oncology" protocols, ensuring treatment efficacy while maintaining quality of life.
Patient Testimonials:
- "I was diagnosed with advanced breast cancer and had lost hope until I met Dr. Akhade. His approach was not just about medicines but about understanding my body and my fears. He put me on a targeted therapy plan that has worked wonders. He is truly a leading oncologist in India for a reason." - S. Mehta
- "Dr. Amol is incredibly knowledgeable and compassionate. When my father needed treatment for lymphoma, Dr. Amol explained every step of the chemotherapy and immunotherapy clearly. We felt safe in his hands, and today my father is in remission. We are forever grateful." - R. Fernandes
- "The level of care provided by Dr. Akhade during my bone marrow transplant was exceptional. He was available to answer our queries and managed the post-transplant complications with great expertise. I highly recommend him to anyone looking for the best cancer care." - A. Singh
Treatment Approach & Philosophy
- Patient-Centred Care: Dr. Akhade believes in a holistic approach where the patient's quality of life is as important as the clinical cure. He engages in multidisciplinary tumour boards to ensure that every patient receives a treatment plan tailored to their specific biological and personal needs.
- Technology & Innovation: As an expert in Medical Oncology, Dr. Akhade integrates the latest advancements in Immunotherapy and Targeted Therapy into his practice. He is a strong advocate for biomarker-driven selection to ensure that patients receive the most effective drugs with minimal unnecessary toxicity. His research into low-dose immunotherapy highlights his commitment to making advanced cancer care accessible and affordable.
Treatment Costs
Dr. Amol Balvant Akhade specialises in Medical Oncology and Bone Marrow Transplants. The costs below are estimated ranges for treatments in India.
Treatment / Procedure | Cost Estimate (INR) | Cost Estimate (USD) |
Chemotherapy (Per Cycle) | ₹15,000 - ₹1,00,000 | $180 - $1,200 |
Immunotherapy (Per Dose) | ₹1,50,000 - ₹4,50,000 | $1,800 - $5,400 |
Targeted Therapy (Monthly) | ₹50,000 - ₹3,00,000 | $600 - $3,600 |
Autologous Bone Marrow Transplant | ₹10,00,000 - ₹15,00,000 | $12,000 - $18,000 |
Allogeneic Bone Marrow Transplant | ₹15,00,000 - ₹25,00,000 | $18,000 - $30,000 |
CAR T-Cell Therapy | ₹30,00,000 - ₹40,00,000 | $36,000 - $48,000 |
Note: For appointment booking and to get a personalised cost estimate, you can connect with the Cancer Rounds team.
International Patient Assistance
- Language Support: The Cancer Rounds team provides dedicated language interpretation services to ensure clear communication between Dr. Akhade and international patients.
- Visa & Travel Assistance: Cancer Rounds assists patients with medical visa invitations, travel itineraries, airport transfers, and accommodation arrangements near the hospital.
- Pre-treatment Virtual Consultations: International patients can book video consultations with Dr. Akhade through Cancer Rounds to discuss medical reports and treatment options before travelling to India.
Frequently Asked Questions
Dr. Amol Balvant Akhade specialises in Medical Oncology and Haemato-Oncology. He is a leading oncologist in India with specific expertise in treating solid tumours, lymphomas, leukaemia, and performing Bone Marrow Transplants (BMT).
Dr. Akhade has over 18 years of experience in the field of oncology, having trained at premier institutes like Tata Memorial Hospital.
Yes, Dr. Akhade is an expert in Immunotherapy and has published extensively on the subject, including research on its use in Head and Neck cancer and cost-effective dosing strategies.
Yes, he is highly skilled in performing both Autologous and Allogeneic Bone Marrow Transplants for patients suffering from haematologic malignancies like myeloma and leukaemia.
He treats a wide range of cancers, including Breast Cancer, Lung Cancer, Head and Neck Cancer, and blood cancers such as Lymphoma and Multiple Myeloma.
You can book an appointment with Dr. Amol Balvant Akhade by contacting the Cancer Rounds team, who will facilitate priority scheduling.
Yes, Dr. Akhade frequently treats international patients. The Cancer Rounds team assists with medical visas, travel, and logistics for patients travelling from abroad.
Yes, patients can arrange a pre-treatment virtual consultation via Cancer Rounds to get a second opinion and discuss their treatment plan before visiting in person.
Dr. Akhade follows a patient-centric, evidence-based approach, utilising Precision Oncology and multidisciplinary tumour boards to design personalised treatment plans involving chemotherapy, targeted therapy, or immunotherapy.
Yes, he is a prolific researcher with publications in top journals like The Lancet Oncology and Journal of Clinical Oncology, focusing on immunotherapy, breast cancer strategies, and geriatric oncology.
Sir H. N. Reliance Foundation Hospital, Mumbai - India
Leukemia Cancer
